A novel two‐lipid signature is a strong and independent prognostic factor in ovarian cancer
- Liina Salminen
- , Elena Ioana Braicu
- , Mitja Lääperi
- , Antti Jylhä
- , Sinikka Oksa
- , Sakari Hietanen
- , Jalid Sehouli
- , Hagen Kulbe
- , Andreas du Bois
- , Sven Mahner
- , Philipp Harter
- , Olli Carpén
- , Kaisa Huhtinen
- , Johanna Hynninen
- , Mika Hilvo*
*Corresponding author for this work
- University of Turku
- Zora Biosciences Oy
- Satasairaala Central Hospital
- Charité Universitätsmedizin Berlin
- University of Duisburg-Essen
- Ludwig Maximilian University of Munich (LMU)
Research output: Contribution to journal › Article › Scientific › peer-review
10
Link opens in a new tab
Citations
(Scopus)